State Street
OPTR

State Street’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

State Street’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-2,226,347
Closed -$28.1M – 3706
2013
Q3 		$28.1M Buy
2,226,347
+540,177
+32% +$7.16M ﹤0.01% 1489
2013
Q2 		$24.4M Buy
+1,686,170
New +$24.6M ﹤0.01% 1505

State Street's OPTR Position: Q4 2013 in Review

State Street sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 2,226,347 shares — an estimated $28.1M sold.

State Street first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $28.1M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • State Street reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • State Street sold 2,226,347 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $28.1M.
  • State Street first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • State Street's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $28.1M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on State Street's 13F filing for Q4 2013, filed 6 Feb 2014.